Startseite » Vaccine studies

We are looking for participants for vaccine studies

Copyright: LMU University Hospital Munich

We are always looking for participants for vaccination studies. If you are interested, we look forward to hearing from you and will be happy to send you more information.

  • Dengue fever vaccine study (information in German)
  • Register for future vaccination studies at the Tropical Institute (see below: General registration)

General registration for vaccination studies at the Tropical Institute

Improved protection against infectious diseases through vaccination
has been an important topic at our institute for many years. Together with renowned vaccine developers, we have been researching and working on new developments and improvements of vaccines for almost 20 years.

Important goals of our clinical studies are e.g. to test the efficacy and safety of a vaccine, to advance improvements, to gain further scientific knowledge as well as to break innovative ground in the field of vaccination.

To be able to conduct studies, we rely on your support:

We are looking for volunteers aged 18 years and older.

If you are interested we look forward to receiving your non-binding registration by e-mail at:

For registration we ask for the following information:

  • Name, first name
  • Date of birth
  • Cell phone number

Your data will be kept strictly confidential and will not be passed on to third parties.

Here you will find an overview of our ongoing vaccination studies

Current vaccination studies

Vaccination studies: recruitment completed


Thank you for your interest!

Your study team at the Institute of Infectious and Tropical Medicine, Munich, Germany


Study coordination
LMU University Hospital
Division of Infectious Diseases and Tropical Medicine
Leopoldstrasse 5
80802 Munich, Germany

Phone: +49 (0)89 4400 59850

Impfstudie_Tropeninstitut_2 Impfstudie_Tropeninstitut_3


Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2.
Kremsner, P.G., Mann, P., Kroidl, A. et al., Wien Klin Wochenschr (2021).

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
, Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
medRxiv 2020.11.09.20228551;

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial, Cassandra Aldrich, Isabel Leroux–Roels, Katell Bidet Huang, Mihai Alexandru Bica, Edde Loeliger, Oliver Schoenborn-Kellenberger, Lisa Walz, Geert Leroux-Roels, Frank von Sonnenburg, Lidia Oostvogels, Vaccine, Volume 39, Issue 8, 2021, Pages 1310-1318, ISSN 0264-410X,


Yellow fever vaccination study: Recruitment completed - thank you to all participants

In our yellow fever vaccine trial which started in September 2021, we are testing a novel yellow fever vaccine (Phase II) against the conventional yellow fever vaccine. [more...]